FCM
INSM icon

Fieldview Capital Management’s Insmed INSM Stock Holding History

Fieldview Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
9,748
+7,549
+343% +$914K 0.3% 84
2026
Q1 		$360K Buy
+2,199
New +$338K 0.11% 335
2025
Q4 		– Sell
-20,229
Closed -$2.91M – 556
2025
Q3 		$2.91M Buy
+20,229
New +$2.48M 0.48% 75

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Fieldview Capital Management's INSM Position: Q2 2026 in Review

Fieldview Capital Management increased its Insmed (INSM) stake by 343% in Q2 2026, buying an estimated $914K and bringing the position to 9,748 shares worth $1.04M. The position accounts for 0.3% of the portfolio, ranked #84.

Fieldview Capital Management first reported a position in INSM in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.91M in Q3 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Fieldview Capital Management held 9,748 shares of Insmed worth $1.04M as of Q2 2026.
  • Fieldview Capital Management bought 7,549 Insmed shares in Q2 2026, an estimated $914K.
  • Insmed made up 0.3% of Fieldview Capital Management's portfolio in Q2 2026, its #84 holding.
  • Fieldview Capital Management first reported a position in Insmed in Q3 2025 and has held it in 3 quarters since.
  • Fieldview Capital Management's Insmed position peaked at $2.91M in Q3 2025.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.